Literature DB >> 8626888

Differentiation between multiple liver hemangiomas and liver metastases of gastrinomas: value of enhanced MRI.

J F Berger1, J P Laissy, O Limot, M C Henry-Feugeas, G Cadiot, M Mignon, E Schouman-Claeys.   

Abstract

PURPOSE: Hepatic metastases of neuroendocrine tumors are known to mimic hemangiomas on nonenhanced SE MR sequences. The usefulness of MR examination with gadolinium injection to identify lesions was prospectively evaluated.
METHOD: Nine patients with multiple liver metastases of gastrinomas were compared with six patients showing multiple liver hemangiomas. Patients underwent unenhanced T2-weighted SE, T1-weighted SE, and FLASH sequences, followed by enhanced sequential FLASH sequences and a 5 min delayed T1-weighted SE sequence.
RESULTS: On T2-weighted SE sequence, all hemangiomas displayed the same typical morphology as a sharply defined, homogeneous, high signal intensity lesion, but this pattern was also observed for some or all of the lesions in seven of nine patients with gastrinoma metastases. Dynamic FLASH sequences were accurate for lesions larger than 2 cm, hemangiomas displaying a nodular peripheral enhancement with centripetal filling in, and metastases displaying either an initial homogeneous or a regular peripheral enhancement. Precise assessment of lesions smaller than 2 cm remained equivocal. Delayed T1-weighted. SE sequence (performed at least 5 min after Gd-chelate injection) was the most accurate technique to identify metastases by showing hypo- or isointensity signal, whereas all hemangiomas were hyperintense.
CONCLUSION: Postcontrast delayed T1-weighted sequence is the primary technique to differentiate equivocal cases of hemangiomas from metastases of gastrinoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626888     DOI: 10.1097/00004728-199605000-00003

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  4 in total

1.  Usefulness of somatostatin receptor scintigraphy in the management of patients with Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE).

Authors:  G Cadiot; G Bonnaud; R Lebtahi; L Sarda; P Ruszniewski; D Le Guludec; M Mignon
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  [Multimodal diagnosis of multiple and heterogeneous liver lesions in a young patient].

Authors:  F Kiessling; H-P Schlemmer
Journal:  Radiologe       Date:  2005-10       Impact factor: 0.635

3.  CT- and ultrasound-characteristics of hepatic lesions in patients with multiple endocrine neoplasia syndrome. A retrospective image review of 25 cases.

Authors:  Nassim Fard; Heinz-Peter Schlemmer; Friedhelm Raue; Björn Jobke
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

Review 4.  Distinguishing benign from malignant liver tumours.

Authors:  Jay P Heiken
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.